Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748 Free article.
Expression of TRPS1 in phyllodes tumor and sarcoma of the breast.
Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Wang J, et al. Among authors: albarracin ct. Hum Pathol. 2022 Mar;121:73-80. doi: 10.1016/j.humpath.2022.01.002. Epub 2022 Jan 19. Hum Pathol. 2022. PMID: 35063444
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. Yoon EC, et al. Among authors: albarracin ct. Hum Pathol. 2022 Jul;125:97-107. doi: 10.1016/j.humpath.2022.04.006. Epub 2022 Apr 9. Hum Pathol. 2022. PMID: 35413381
Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases.
Zhou P, Chang N, Abraham SC, Albarracin CT, Huo L, Chen H, Ding Q, Resetkova E, Middleton LP, Sahin AA, Bu H, Wu Y. Zhou P, et al. Among authors: albarracin ct. Hum Pathol. 2022 Jul;125:59-67. doi: 10.1016/j.humpath.2022.04.009. Epub 2022 Apr 18. Hum Pathol. 2022. PMID: 35447141 Review.
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
Wang M, Ding Q, Gu J, Sfamenos SM, Huo L, Tang Z, Sun H, Robinson M, Tang G, Lim B, Wu Y, Albarracin CT, Sahin AA, Chen H. Wang M, et al. Among authors: albarracin ct. Clin Breast Cancer. 2023 Jun;23(4):415-422. doi: 10.1016/j.clbc.2023.02.006. Epub 2023 Feb 12. Clin Breast Cancer. 2023. PMID: 36878823
Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Zheng L, et al. Cancers (Basel). 2023 Dec 19;16(1):6. doi: 10.3390/cancers16010006. Cancers (Basel). 2023. PMID: 38201434 Free PMC article.
107 results